CE MARK

articles with this tag

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.

Thanks for subscribing!

X